Literature DB >> 15572548

Granulocyte markers in hypertonic and isotonic saline-induced sputum of asthmatic subjects.

S Cianchetti1, E Bacci, L Ruocco, M L Bartoli, M Ricci, T Pavia, F L Dente, A Di Franco, B Vagaggini, P L Paggiaro.   

Abstract

The aim of this study was to assess whether hyperosmolarity affects granulocyte mediator levels in induced sputum of asthmatic subjects. A total of 32 mild-to-moderate asthmatics, who inhaled either hypertonic (HS; 4.5% NaCl) or isotonic (IS; 0.9% NaCl) solutions for 15 min, were studied. Selected sputum was used for analysis. Eosinophil cationic protein (ECP), eosinophil protein X (EPX), myeloperoxidase (MPO) and free neutrophil elastase (NE) were measured in sputum supernatant. Sample weight, total and differential cell counts, as well as viability and squamous cell percentage were no different after the two tests. No significant differences in ECP, EPX, MPO or NE levels were observed between HS- and IS-induced sputum. Repeatability of the two tests was good for macrophages, neutrophils, eosinophils, ECP, EPX and NE, but not for lymphocytes and MPO. In conclusion, hyperosmolarity does not affect sputum cell counts and the levels of most granulocyte degranulation markers examined in this study, confirming that both hypertonic and isotonic solutions can be reliably used to induce sputum in asthmatics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572548     DOI: 10.1183/09031936.04.00139503

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Exhaled breath analysis: from occupational to respiratory medicine.

Authors:  Massimo Corradi; Antonio Mutti
Journal:  Acta Biomed       Date:  2005

Review 2.  Anti-inflammatory therapies for cystic fibrosis-related lung disease.

Authors:  David P Nichols; Michael W Konstan; James F Chmiel
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

3.  Contribution by polymorphonucleate granulocytes to elevated gamma-glutamyltransferase in cystic fibrosis sputum.

Authors:  Alessandro Corti; Maria Franzini; Silvana Cianchetti; Gabriella Bergamini; Evelina Lorenzini; Paola Melotti; Aldo Paolicchi; Pierluigi Paggiaro; Alfonso Pompella
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

4.  Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients.

Authors:  Ankan Bandyopadhyay; Partha P Roy; Kaushik Saha; Semanti Chakraborty; Debraj Jash; Debabrata Saha
Journal:  Lung India       Date:  2013-04

5.  Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases.

Authors:  M L Bartoli; F Novelli; F Costa; L Malagrinò; L Melosini; E Bacci; S Cianchetti; F L Dente; A Di Franco; B Vagaggini; P L Paggiaro
Journal:  Mediators Inflamm       Date:  2011-06-16       Impact factor: 4.711

6.  Efficacy of add-on montelukast in nonasthmatic eosinophilic bronchitis: the additive effect on airway inflammation, cough and life quality.

Authors:  Wuping Bao; Ping Liu; Zhongmin Qiu; Li Yu; Jingqing Hang; Xiaohua Gao; Xin Zhou
Journal:  Chin Med J (Engl)       Date:  2015-01-05       Impact factor: 2.628

7.  Correlation of total serum immunoglobulin E level, sputum, and peripheral eosinophil count in assessing the clinical severity in bronchial asthma.

Authors:  Roshan M Kumar; R Pajanivel; G Koteeswaran; Surendra K Menon; Pravin Mv Charles
Journal:  Lung India       Date:  2017 May-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.